Engineering nanomedicines for improved melanoma therapy: progress and promises. - Wikidata - wikimedia - TriplyDB

Engineering nanomedicines for improved melanoma therapy: progress and promises.

Engineering nanomedicines for improved melanoma therapy: progress and promises.

http://www.wikidata.org/entity/Q36936646

about

Nanotechnology-based cosmeceuticals Drug delivery nanoparticles in skin cancers Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models Bacterial-Derived Polymer Poly-γ-Glutamic Acid (γ-PGA)-Based Micro/Nanoparticles as a Delivery System for Antimicrobials and Other Biomedical Applications Delivery of size-controlled long-circulating polymersomes in solid tumours, visualized by quantum dots and optical imaging in vivo.Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models.Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics.Permeation enhancer strategies in transdermal drug delivery.Anticancer Activities of Surfactin and Potential Application of Nanotechnology Assisted Surfactin Delivery.Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment.Interaction of pH-sensitive non-phospholipid liposomes with cellular mimetic membranes.Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment.Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model.

P2860

Q26828457-FF2CD89D-3DCD-46E3-8B69-0897B55069DA Q28390405-D91CC1E0-C3AE-40CB-8FB2-2F2F6A32F444 Q28817211-52B15E20-A753-4B6B-84E5-92E7F235B99B Q29248031-D4B2A5BB-15B7-4368-8F5B-F3E1A3A4405F Q35613961-9EAC4283-1461-4113-9176-894E8E41BDF7 Q36766846-945D9532-2B3E-4E0C-B7EC-AADE05A457BB Q38127412-C12B0230-0167-4478-834F-A3195501F076 Q38227590-736EE49C-6CBF-48A9-B930-6D0F4D955C91 Q45988894-E8023254-2398-46FB-B196-F25AF42992C8 Q46026100-C763233C-A5E7-4ABA-B724-124D81CBC79B Q46477273-54FF8EBA-E6E3-42D8-84CA-AC1AB716D75B Q47682175-2A510F6A-03F2-4607-A6A7-6C510FD61DA8 Q53497534-6F7EEDDE-3887-4D31-A561-9CC71F07C977

P2860

Engineering nanomedicines for improved melanoma therapy: progress and promises.

http://www.wikidata.org/entity/Q36936646

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Engineering nanomedicines for improved melanoma therapy: progress and promises.

@en

type

label

Engineering nanomedicines for improved melanoma therapy: progress and promises.

@en

prefLabel

Engineering nanomedicines for improved melanoma therapy: progress and promises.

@en

P1433

Q36936646-2C43E74D-B47F-459B-9FA3-B3F3682EF9BC

P1476

Q36936646-D6CF00FB-0A5F-4C7F-8F3E-BB9787EDFC08

P2093

Q36936646-0AE3EF35-D7C1-4DEF-9139-F46EEE97E5A7

Q36936646-6D48A10A-7115-4E64-8923-D727F3B94D67

Q36936646-93444BF5-3019-4412-9704-4D9D4867F1B5

P2860

Q36936646-004B7C20-0C46-48D7-B8A0-3A959F956EC8

Q36936646-053C705E-750F-4BED-9651-C1DB2A43E3ED

Q36936646-05EFA10B-2DE8-4ADB-B5B4-5E86D095CD83

Q36936646-07B264E3-A330-494B-88D8-9A6699710A6F

Q36936646-0A61A9A2-503F-4D9A-AC9F-A28DF37D14AE

Q36936646-0B0F45A3-C37D-4041-93AA-068EF6A3A2CC

Q36936646-0D4DA8B4-9329-4F8B-AAB3-A79A973F87D8

Q36936646-0F1D1365-8B25-48C5-BEDD-6446755624FA

Q36936646-1220061D-93CA-4B9A-A8C4-E573FAB58BA7

Q36936646-143289E1-E9EC-42FB-B3A5-3FE060A06EE9

P304

Q36936646-E306668F-186D-4E6D-8DD7-6F18A684E234

P31

Q36936646-1f7d9f5a-d1e2-4d6d-a984-8c56a889b6ef

Q36936646-FA08B408-B472-4A64-94E4-9BD5E4897653

P356

Q36936646-AFA6827E-61C1-479A-9F83-FE482882FBB3

P433

Q36936646-A8DC603F-5705-441D-B281-49702AC7BE30

P478

Q36936646-AF330BF9-61A6-41A4-91A1-3E698C0BDFCE

P577

Q36936646-F0617110-4E4E-4744-A81F-EC5ADAB5D657

P698

Q36936646-BF51D239-578D-48C4-AD54-2F58D01A3DFE

P932

Q36936646-3B0E61DF-CCF5-4840-A40E-3C29A77CC8CA

P356

P1433

P1476

Engineering nanomedicines for improved melanoma therapy: progress and promises.

@en

P2093

Bi-Botti C Youan

http://www.w3.org/2001/XMLSchema#string

Di Bei

http://www.w3.org/2001/XMLSchema#string

Jianing Meng

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Safe handling of nanotechnology

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

Polymersomes: a new multi-functional tool for cancer diagnosis and therapy.

Emulsified microemulsions and oil-containing liquid crystalline phases.

Control of the internal structure of MLO-based isasomes by the addition of diglycerol monooleate and soybean phosphatidylcholine.

Peptide and amide bond-containing dendrimers.

Characterisation of drug release from cubosomes using the pressure ultrafiltration method.

Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.

Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas.

P304

1385-1399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.10.117

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21128721

http://www.w3.org/2001/XMLSchema#string

P932

3685319

http://www.w3.org/2001/XMLSchema#string